OTC & Nutraceuticals APAC

APAC Smoking Cessation Products Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Smoking Cessation Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $872.3 Mn Placeholder estimate
Estimate 2025 $923.8 Mn 20.9% of the global market
Projected 2034 $1.55 Bn 67.5% Adds $623.7 Mn over 9 forecast years
CAGR 2025–2034 5.9% Faster than 7% of 82 OTC & Nutraceuticals markets here
Key players 5
  • APAC is 20.95% of the global market.
  • Among regions, the largest is North America at $2.19 Bn.
  • Fastest growing: Latin America at 6.1% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$623.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Smoking Cessation Products Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $872.3 Mn — —
2025 (base) $923.8 Mn +$51.5 Mn —
2026 (forecast) $978.3 Mn +$54.5 Mn +5.9%
2027 (forecast) $1.04 Bn +$57.7 Mn +12.1%
2028 (forecast) $1.10 Bn +$61.1 Mn +18.8%
2029 (forecast) $1.16 Bn +$64.7 Mn +25.8%
2030 (forecast) $1.23 Bn +$68.5 Mn +33.2%
2031 (forecast) $1.30 Bn +$72.6 Mn +41.1%
2032 (forecast) $1.38 Bn +$76.9 Mn +49.4%
2033 (forecast) $1.46 Bn +$81.4 Mn +58.2%
2034 (forecast) $1.55 Bn +$86.2 Mn +67.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Smoking Cessation Products Market Analysis at a glance
Market size, 2025$923.8 Mn placeholder estimate
Forecast, 2034$1.55 Bn placeholder estimate
Growth (CAGR), 2025–20345.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, form and distribution channel (see all)
Key playersHaleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc, Cipla Inc. (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Smoking Cessation Products Market Analysis Executive Summary

Smoking cessation products help people quit smoking, including nicotine patches, gums, sprays, medicines and quit apps.

Key segments of the smoking Cessation Products market include product (Nicotine Replacement Therapy, Prescription Drugs and Digital Quit Programs) and form (Patches, Gum and Lozenges and Sprays and Inhalers).

Bar chart: Asia Pacific Smoking Cessation Products market size, 2024–2034, placeholder estimates. $872.3 Mn in 2024, $923.8 Mn in 2025 and $1.55 Bn in 2034, 5.9% CAGR.
Asia Pacific Smoking Cessation Products market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Smoking Cessation Products Market Dynamics

Market Growth Drivers

More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.

Opportunity

Ready-to-use formulations, biosimilars and supply security programmes give the smoking Cessation Products market room to grow.

Market Restraints

Drug shortages, price controls, generic competition and strict hospital budgets hold back the smoking Cessation Products market.

Competitive Landscape for Smoking Cessation Products Market in APAC

The smoking Cessation Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Smoking Cessation Products Market in APAC

Smoking Cessation Products in APAC: rules

In some of the countries we cover here, medicines are approved by TGA (Australia)⁠[1], NMPA (China)⁠[2], Drug Office (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], NPRA (Malaysia)⁠[6], Medsafe (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9] and Thai FDA (Thailand)⁠[10]. In some of the countries we cover here, supplement rules come from TGA (Australia)⁠[1], SAMR (China)⁠[11], Centre for Food Safety (Hong Kong)⁠[12], FSSAI (India)⁠[13], Consumer Affairs Agency (Japan)⁠[14], NPRA (Malaysia)⁠[6], MPI (New Zealand)⁠[15], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9] and Thai FDA (Thailand)⁠[10].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Drug Office, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] State Administration for Market Regulation. Checked 14 Nov 2026.

[12] Centre for Food Safety. Checked 14 Nov 2026.

[13] Food Safety and Standards Authority of India. Checked 14 Nov 2026.

[14] Consumer Affairs Agency. Checked 14 Nov 2026.

[15] Ministry for Primary Industries. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern smoking Cessation Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Smoking Cessation Products right now, from free public sources.

Patients

Smoking (adults), % of adults (World Bank)
CountryValueYear
Afghanistan22.12024
Australia11.62024
Bangladesh32.02024
China22.82024
India22.62024
Indonesia31.02024
Japan17.52024
Malaysia16.92024
Myanmar43.42024
Nepal28.72024
New Zealand9.32024
Pakistan17.92024
Philippines19.92024
Singapore13.82024
Thailand17.82024
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Smoking Cessation Products in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Smoking Cessation Products market in Asia Pacific?
Placeholder estimate: about $923.8 Mn in 2025, rising to about $1.55 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Smoking Cessation Products market in Asia Pacific growing?
Placeholder estimate: about 5.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Smoking Cessation Products market report cover?
The report splits the market by product (Nicotine Replacement Therapy, Prescription Drugs, Digital Quit Programs), form (Patches, Gum and Lozenges, Sprays and Inhalers, Tablets) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the Smoking Cessation Products market?
Key players include Haleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc and Cipla Inc..
What is driving the Smoking Cessation Products market?
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.
How much research is published on Smoking Cessation Products?
PubMed lists 9,665 papers on Smoking Cessation Products added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in APAC

See all

Related on smoking and respiratory

See the topic